OOIR: Observatory of International Research

Papers

(The TQCC of Annual Review of Medicine is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
The Gut–Brain Axis	213
Phage Therapy for Antibiotic-Resistant Bacterial Infections	212
mRNA Vaccines in the COVID-19 Pandemic and Beyond	133
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment	101
Hepatocellular Carcinoma Immunotherapy	98
The Role of Exercise in Management of Mental Health Disorders: An Integrative Review	96
Hepcidin and Iron in Health and Disease	91
The Gut Microbiome and Inflammatory Bowel Diseases	81
Engineering IL-2 to Give New Life to T Cell Immunotherapy	76
Diagnosis and Treatment of Helicobacter pylori Infection	67
Cardiovascular Effects of Particulate Air Pollution	64
New Therapeutics for Ulcerative Colitis	62
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines	62
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies	60
Post-COVID-19 Condition	60
COVID-19 and Diabetes	59
COVID-19: Challenges of Viral Variants	53
Direct-to-Consumer Genetic Testing: Value and Risk	50
Hematopoietic Stem Cell Transplantation for Autoimmune Disease	48
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches	48
COVID-19: Inflammatory Profile	46
Advances in Chronic Obstructive Pulmonary Disease	46
Synchronizing Brain Rhythms to Improve Cognition	45
New Therapeutics for Hepatitis B: The Road to Cure	44
COVID-19 Vaccines: Adenoviral Vectors	44

Clinical Perspectives on IgG4-Related Disease and Its Classification	43
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches	42
Therapeutics Targeting Mutant KRAS	42
Aspirin in the Prevention of Colorectal Neoplasia	41
Cytokine Storm Syndrome	40
Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities	40
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone	38
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression	38
Toward Better Understanding and Management of CAR-T Cell–Associated Toxicity	36
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy	35